Industry Is Adapting To New Pricing Reality, Says GSK Chief Andrew Witty
This article was originally published in The Pink Sheet Daily
Executive Summary
Andrew Witty shines a positive light on value-based pricing and adds his voice to calls for harmonized HTAs across Europe.